Related Experiment Video

Updated: Mar 23, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.4K

U-73122 reduces the cell growth in cultured MG-63 ostesarcoma cell line involving Phosphoinositide-specific

Vincenza Rita Lo Vasco1, Martina Leopizzi2, Valeria Di Maio2

  • 1Sensory Organs Department, Policlinico Umberto I, Faculty of Medicine and Dentistry, Sapienza University of Rome, viale dell'Università, 33, 00157 Rome, Italy.

Springerplus
|March 31, 2016
PubMed

Insights

Phosphatidylinositol (4,5)-bisphosphate (PIP2) and Phospholipase C (PLC) enzymes impact osteosarcoma cell growth. Inhibiting PLC with U-73122 reduces MG-63 cell viability, suggesting a role for this pathway in osteosarcoma progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Osteosarcoma metastasis involves complex signal transduction pathways.
  • Phosphatidylinositol (4,5)-bisphosphate (PIP2) and its regulation by Phospholipase C (PLC) are implicated in cell signaling.
  • Ezrin, a protein linked to metastasis, interacts with PIP2 and potentially Ras GTPases.

Purpose of the Study:

  • To investigate the role of Phospholipase C (PLC) enzymes in human osteosarcoma MG-63 cells.
  • To analyze the expression and subcellular localization of PLC isoforms.
  • To determine the effect of PLC inhibition on osteosarcoma cell viability and PLC expression.

Main Methods:

  • Cultured human osteosarcoma MG-63 cells were used as a model.
  • Cells were treated with the PLC inhibitor U-73122 and its inactive analog U-73343.
  • Ezrin was silenced to assess its role.
  • Expression and subcellular localization of PLC isoforms were analyzed.

Main Results:

  • Treatment with U-73122 significantly reduced the number of viable MG-63 cells.
  • U-73122 altered the expression and subcellular localization of specific PLC isoforms.
  • These findings suggest PI-specific Phospholipases C are involved in reducing osteosarcoma cell growth.

Conclusions:

  • Phospholipase C (PLC) activity is crucial for osteosarcoma cell viability.
  • Targeting PLC may offer novel therapeutic strategies for osteosarcoma.
  • Understanding PLC's role in osteosarcoma pathogenesis can refine prognosis and treatment.
Keywords:
DMSOMG-63OncologyOsteosarcomaPhosphoinositidePhospholipase CU-73122U-73343

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

8.7K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K